Regeneron Pharmaceuticals, Inc.

Geneos Wealth Management Inc. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

820

Value ($000)

633

Weight

0.0%

2016 Q1 - 2025 Q4 (40 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	633	0.0%	820	12/31/2025
2025 Q3	10/22/2025	496	0.0%	882	9/30/2025
2025 Q2	8/18/2025	410	0.0%	780	6/30/2025
2025 Q1	5/8/2025	488	0.0%	770	3/31/2025
2024 Q4	1/21/2025	492	0.0%	690	12/31/2024
2024 Q3	11/14/2024	722	0.0%	687	9/30/2024
2024 Q2	7/23/2024	847	0.0%	806	6/30/2024
2024 Q1	5/3/2024	814	0.0%	846	3/31/2024
2023 Q4	1/26/2024	759	0.0%	864	12/31/2023
2023 Q3	10/11/2023	746	0.0%	906	9/30/2023
2023 Q2	8/8/2023	724	0.0%	1,008	6/30/2023
2023 Q1	4/25/2023	852	0.1%	1,037	3/31/2023
2022 Q4	1/31/2023	784	0.0%	1,086	12/31/2022
2022 Q3	11/14/2022	773	0.1%	1,123	9/30/2022
2022 Q2	7/22/2022	663	0.0%	1,115	6/30/2022
2022 Q1	5/16/2022	822	0.0%	1,177	3/31/2022
2021 Q4	2/9/2022	762	0.0%	1,207	12/31/2021
2021 Q3	11/9/2021	702	0.0%	1,230	9/30/2021
2021 Q2	7/8/2021	829	0.0%	1,421	6/30/2021
2021 Q1	6/17/2021	750	0.0%	1,559	3/31/2021
2020 Q4	5/19/2021	767	0.0%	1,611	12/31/2020
2020 Q3	9/7/2021	198	0.0%	346	9/30/2020
2020 Q2	9/7/2021	208	0.0%	341	6/30/2020
2020 Q1	9/7/2021	245	0.0%	537	3/31/2020
2019 Q4	9/7/2021	193	0.0%	517	12/31/2019
2019 Q3	9/7/2021	141	0.0%	517	9/30/2019
2019 Q2	9/7/2021	161	0.0%	517	6/30/2019
2019 Q1	9/7/2021	212	0.0%	517	3/31/2019
2018 Q4	9/7/2021	184	0.0%	510	12/31/2018
2018 Q3	9/7/2021	222	0.0%	550	9/30/2018
2018 Q2	9/7/2021	189	0.0%	550	6/30/2018
2018 Q1	9/7/2021	195	0.0%	567	3/31/2018
2017 Q4	9/7/2021	213	0.0%	567	12/31/2017
2017 Q3	9/7/2021	253	0.0%	567	9/30/2017
2017 Q2	9/7/2021	278	0.0%	568	6/30/2017
2017 Q1	9/7/2021	223	0.0%	578	3/31/2017
2016 Q4	9/7/2021	216	0.0%	589	12/31/2016
2016 Q3	9/7/2021	236	0.0%	589	9/30/2016
2016 Q2	9/7/2021	207	0.0%	578	6/30/2016
2016 Q1	9/7/2021	234	0.0%	578	3/31/2016